BiologicsSpine

Vertebral Technologies, Inc. Announces 400 th Implant of the InterFuse® Interbody Fusion Device

Minneapolis, October 22, 2009 Vertebral Technologies, Inc. (VTI), a Minnetonka, MN
based spinal implant manufacturer announces the 400 th implant of the InterFuse ® Interbody Fusion Device. The Interfuse device uses VTI’s patented Intraoperative Assembly™ technology to assemble a large implant through a minimally invasive surgical approach. The Unilateral Posterior Lumbar Interbody Fusion (UPLIF ® ) procedure uses a single posterior incision to access the disc, reducing tissue dissection and nerve root retraction while preserving the facet joints. VTI has completed Phase I of their pilot launch and is currently expanding commercial distribution of the InterFuse Interbody Fusion System.

Manuel R. Pinto, M.D., Clinical Assistant Professor at the University of Minnesota and staff surgeon at Twin Cities Spine Center said, “The InterFuse Interbody Fusion System combines my preferred minimally invasive posterior surgical approach to the spine with a larger implant footprint than other implants. This combination provides superior anterior spinal column support while significantly reducing postoperative pain.”

Jeffrey Felt, M.D., Chief Executive Officer of VTI, comments, “The continued growth in sales of the Interfuse Interbody Fusion Device and the excellent patient outcomes reported validates our Intraoperative Assembly approach to implanting large devices through minimal access surgery. VTI is already expanding this concept to other surgical approaches for both fusion and nonfusion devices, particularly the InterCushion® Disc Nucleus Replacement Device.”

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button